MapmyGenome raises Pre Series A round of funding

MapmyGenome raises Pre Series A round of funding - Mapmygenome

MapmyGenome Raises Pre-Series A Round of Funding

Hyderabad, India — March 10, 2015: MapmyGenome, pioneers of personal genomics in India, have raised a Pre-Series A round of funding from multiple angel investors including Aarti Grover MD (CMS Computers), Rajan Anandan MD (Google India), Arihant Patni (Hive Technologies), and Satveer Singh Thakral (CEO, Singapore Angel Network). Avendus Wealth Management Pvt. Ltd. served as advisors.

“This round of funding will help in scaling up our operations in India and globally. We are looking to expand our team where our focus is on quality of talent — education and expertise. We are also looking to invest in some assets and scale up our research.” — Anu Acharya, CEO, MapmyGenome

“As India’s economy develops, we strongly believe that preventive healthcare will form a rising share of the household budget. Genome mapping is at the frontier of technological innovation in this context.” — Satveer Singh Thakral, CEO, Singapore Angel Network

About MapmyGenome India

MapmyGenome India offers services in personal genomics, molecular diagnostics, DNA forensics, and brain wellness. As pioneers of personal genomics in India, they created a new market for predictive tests with their flagship brand Genomepatri™ in April 2013. In February 2014, the Government of Karnataka awarded them the Bio Excellence award “Emerging Company of the Year”.


India’s Pioneer in Personal Genomics

Genomepatri by MapmyGenome is India’s most comprehensive at-home DNA wellness test — covering 100+ health conditions, nutrition, fitness, and drug response traits. Backed by certified genetic counsellors and a CAP & NABL-accredited laboratory.

Explore Genomepatri →

একটি মন্তব্য লিখুন

দয়া করে লক্ষ্য করুন, মন্তব্যগুলি প্রকাশের আগে অনুমোদিত হতে হবে।

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.